130 related articles for article (PubMed ID: 20845477)
1. Glucose metabolism gene polymorphisms and clinical outcome in pancreatic cancer.
Dong X; Tang H; Hess KR; Abbruzzese JL; Li D
Cancer; 2011 Feb; 117(3):480-91. PubMed ID: 20845477
[TBL] [Abstract][Full Text] [Related]
2. Glucose metabolism gene variants modulate the risk of pancreatic cancer.
Dong X; Li Y; Chang P; Tang H; Hess KR; Abbruzzese JL; Li D
Cancer Prev Res (Phila); 2011 May; 4(5):758-66. PubMed ID: 21411499
[TBL] [Abstract][Full Text] [Related]
3. Single nucleotide polymorphisms of gemcitabine metabolic genes and pancreatic cancer survival and drug toxicity.
Okazaki T; Javle M; Tanaka M; Abbruzzese JL; Li D
Clin Cancer Res; 2010 Jan; 16(1):320-9. PubMed ID: 20028759
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor axis gene polymorphisms and clinical outcomes in pancreatic cancer.
Dong X; Javle M; Hess KR; Shroff R; Abbruzzese JL; Li D
Gastroenterology; 2010 Aug; 139(2):464-73, 473.e1-3. PubMed ID: 20416304
[TBL] [Abstract][Full Text] [Related]
5. Effects of base excision repair gene polymorphisms on pancreatic cancer survival.
Li D; Li Y; Jiao L; Chang DZ; Beinart G; Wolff RA; Evans DB; Hassan MM; Abbruzzese JL
Int J Cancer; 2007 Apr; 120(8):1748-54. PubMed ID: 17230526
[TBL] [Abstract][Full Text] [Related]
6. SPARC gene variants predict clinical outcome in locally advanced and metastatic pancreatic cancer patients.
Arqueros C; Salazar J; Arranz MJ; Sebio A; Mora J; Sullivan I; Tobeña M; Martín-Richard M; Barnadas A; Baiget M; Páez D
Med Oncol; 2017 Aug; 34(8):136. PubMed ID: 28687963
[TBL] [Abstract][Full Text] [Related]
7. Association between somatostatin receptor 5 gene polymorphisms and pancreatic cancer risk and survival.
Li D; Tanaka M; Brunicardi FC; Fisher WE; Gibbs RA; Gingras MC
Cancer; 2011 Jul; 117(13):2863-72. PubMed ID: 21692047
[TBL] [Abstract][Full Text] [Related]
8. Genetic variability of the ABCC2 gene and clinical outcomes in pancreatic cancer patients.
Gentiluomo M; Puchalt García P; Galeotti AA; Talar-Wojnarowska R; Tjaden C; Tavano F; Strobel O; Kupcinskas J; Neoptolemos J; Hegyi P; Costello E; Pezzilli R; Sperti C; Lawlor RT; Capurso G; Szentesi A; Soucek P; Vodicka P; Lovecek M; Hackert T; Cavestro GM; Milanetto AC; Canzian F; Campa D
Carcinogenesis; 2019 Jun; 40(4):544-550. PubMed ID: 30629142
[TBL] [Abstract][Full Text] [Related]
9. DNA mismatch repair gene polymorphisms affect survival in pancreatic cancer.
Dong X; Li Y; Hess KR; Abbruzzese JL; Li D
Oncologist; 2011; 16(1):61-70. PubMed ID: 21212431
[TBL] [Abstract][Full Text] [Related]
10. Association of multi-drug resistance gene polymorphisms with pancreatic cancer outcome.
Tanaka M; Okazaki T; Suzuki H; Abbruzzese JL; Li D
Cancer; 2011 Feb; 117(4):744-51. PubMed ID: 20922799
[TBL] [Abstract][Full Text] [Related]
11. Distribution of cholecystokinin-B receptor genotype between patients with pancreatic cancer and controls and its impact on survival.
Smith JP; Whitcomb DC; Matters GL; Brand RE; Liao J; Huang YJ; Frazier ML
Pancreas; 2015 Mar; 44(2):236-42. PubMed ID: 25469546
[TBL] [Abstract][Full Text] [Related]
12. CD24 and APC Genetic Polymorphisms in Pancreatic Cancers as Potential Biomarkers for Clinical Outcome.
Shamai S; Nabiochtchikov I; Kraus S; Zigdon S; Kazanov D; Itzhak-Klutch M; Eizner C; Arber N; Geva R
PLoS One; 2015; 10(9):e0134469. PubMed ID: 26394139
[TBL] [Abstract][Full Text] [Related]
13. Association of Germline Variants in Human DNA Damage Repair Genes and Response to Adjuvant Chemotherapy in Resected Pancreatic Ductal Adenocarcinoma.
Hu H; Zhu Y; Pu N; Burkhart RA; Burns W; Laheru D; Zheng L; He J; Goggins MG; Yu J
J Am Coll Surg; 2020 Nov; 231(5):527-535.e14. PubMed ID: 32659497
[TBL] [Abstract][Full Text] [Related]
14. Impact of TP53 codon 72 and MDM2 SNP 309 polymorphisms in pancreatic ductal adenocarcinoma.
Hori Y; Miyabe K; Yoshida M; Nakazawa T; Hayashi K; Naitoh I; Shimizu S; Kondo H; Nishi Y; Umemura S; Kato A; Ohara H; Inagaki H; Joh T
PLoS One; 2015; 10(3):e0118829. PubMed ID: 25734904
[TBL] [Abstract][Full Text] [Related]
15. Identification and Validation of a Biomarker Signature in Patients With Resectable Pancreatic Cancer via Genome-Wide Screening for Functional Genetic Variants.
Dimitrakopoulos C; Vrugt B; Flury R; Schraml P; Knippschild U; Wild P; Hoerstrup S; Henne-Bruns D; Wuerl P; Graf R; Breitenstein S; Bond G; Beerenwinkel N; Grochola LF
JAMA Surg; 2019 Jun; 154(6):e190484. PubMed ID: 30942874
[TBL] [Abstract][Full Text] [Related]
16. Effect of neoadjuvant radiotherapy on survival of non-metastatic pancreatic ductal adenocarcinoma: a SEER database analysis.
Wang D; Liu C; Zhou Y; Yan T; Li C; Yang Q; Xu Y; Zhao L; Pei Q; Tan F; Güngör C; Li Y
Radiat Oncol; 2020 May; 15(1):107. PubMed ID: 32404114
[TBL] [Abstract][Full Text] [Related]
17. A novel hotspot and rare somatic mutation p.A138V, at TP53 is associated with poor survival of pancreatic ductal and periampullary adenocarcinoma patients.
Saha G; Singh R; Mandal A; Das S; Chattopadhyay E; Panja P; Roy P; DeSarkar N; Gulati S; Ghatak S; Ghosh S; Banerjee S; Roy B; Ghosh S; Chaudhuri D; Arora N; Biswas NK; Sikdar N
Mol Med; 2020 Jun; 26(1):59. PubMed ID: 32552660
[TBL] [Abstract][Full Text] [Related]
18. Overall survival of patients with recurrent pancreatic cancer treated with systemic therapy: a retrospective study.
Gbolahan OB; Tong Y; Sehdev A; O'Neil B; Shahda S
BMC Cancer; 2019 May; 19(1):468. PubMed ID: 31101022
[TBL] [Abstract][Full Text] [Related]
19. Single nucleotide polymorphism in the microRNA-199a binding site of HIF1A gene is associated with pancreatic ductal adenocarcinoma risk and worse clinical outcomes.
Wang X; Ren H; Zhao T; Ma W; Dong J; Zhang S; Xin W; Yang S; Jia L; Hao J
Oncotarget; 2016 Mar; 7(12):13717-29. PubMed ID: 26872370
[TBL] [Abstract][Full Text] [Related]
20. A Sub-Type of Familial Pancreatic Cancer: Evidence and Implications of Loss-of-Function Polymorphisms in Indoleamine-2,3-Dioxygenase-2.
Nevler A; Muller AJ; Cozzitorto JA; Goetz A; Winter JM; Yeo TP; Lavu H; Yeo CJ; Prendergast GC; Brody JR
J Am Coll Surg; 2018 Apr; 226(4):596-603. PubMed ID: 29426021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
